Full Press Release Details
Priveterra Acquisition Corp. Announces
Pricing of Upsized $240 Million Initial Public Offering
Fort Lauderdale, FL - February 8, 2021 -
Priveterra Acquisition Corp. (the "Company") today announced the pricing of its initial public offering of 24,000,000
units at a price of $10.00 per unit. The units will be listed on the Nasdaq Capital Market ("Nasdaq") and trade under
the ticker symbol "PMGMU" beginning on February 9, 2021. Each unit consists of one share of Class A common
stock and one-third of one redeemable warrant, with each whole warrant exercisable to purchase one share of Class A common
stock at a price of $11.50 per share. Only whole warrants will be exercisable. Once the securities comprising the units begin separate
trading, the shares of Class A common stock and warrants are expected to be listed on Nasdaq under the symbols "PMGM"
and "PMGMW," respectively.
Priveterra Acquisition Corp. is a blank-check company formed
for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business
combination with one or more businesses. The Company intends to focus on the healthcare industry, particularly the medical technology
Wells Fargo Securities and Guggenheim Securities are acting
as the joint book-runners for the offering. Odeon Capital Group is acting as co-manager for the offering. The Company has granted
the underwriters a 45-day option to purchase up to an additional 3,600,000 units at the initial public offering price to cover
over-allotments, if any.
The offering is being made only by means of a prospectus. When
available, copies of the prospectus relating to this offering may be obtained from Wells Fargo Securities, LLC, Attention: Equity
Syndicate Department, 500 West 33rd Street, New York, New York, 10001, at (800) 326-5897 or emailing a request to cmclientsupport@wellsfargo.com
and Guggenheim Securities, LLC, Attention: Equity Syndicate Department, 330 Madison Avenue, New York, NY 10017 or by telephone
at (212) 518-5548, or by email at GSEquityProspectusDelivery@guggenheimpartners.com.
A registration statement relating to these securities was declared
effective by the U.S. Securities and Exchange Commission (the "SEC") on February 8, 2021. This press release shall
not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any
state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under
the securities laws of any such state or jurisdiction.
Forward Looking-Statements
This press release contains statements that constitute "forward-looking
statements," including with respect to the initial public offering and search for an initial business combination. No assurance
can be given that the offering discussed above will be completed on the terms described, or at all, or that the proceeds of the
offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the
control of the Company, including those set forth in the Risk Factors section of the Company's registration statement for
the initial public offering filed with the SEC. Copies are available on the SEC's website, www.sec.gov. The Company undertakes
no obligation to update these statements for revisions or changes after the date of this release, except as required by law.
Chief Legal Officer and Secretary
Priveterra Acquisition Corp.